.....is it possible that AstraZeneca said no to Pfizer because they would like to become partners with Insmed? Maybe they heard earlier that Mr Brennan was going to join the Insmed board. Any thoughts?
Why wouldn't either of these big pharmas not want to have this in their pipeline eventually?
I hardly doubt that acquisition talks broke down over INSM, but as news of this deal falling through hit the wires, I must admit, it brought a slight smile to my face.